[Federal Register Volume 69, Number 24 (Thursday, February 5, 2004)]
[Notices]
[Page 5554]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-2376]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Initial Review 
Group, Subcommittee H--Clinical Groups.
    Date: March 22, 2004.
    Time: 7:30 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard Crystal City, 2899 Jefferson Davis Highway, 
Arlington, VA 22202.
    Contact Person: Deborah R. Jaffe, PhD, Scientific Review 
Administrator, Resources and Training Review Branch, National Cancer 
Institute, Division of Extramural Activities, 6116 Executive Blvd., 
Rm 8135, Bethesda, MD 20892, (301) 496-7721, [email protected].

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 28, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-2376 Filed 2-4-04; 8:45 am]
BILLING CODE 4140-01-M